皮肤镜市场 - 全球产业规模、份额、趋势、机会及预测（按产品、技术、模式、应用、最终用户、地区和竞争格局划分），2021-2031年

全球皮肤镜市场预计将从 2025 年的 9.6791 亿美元成长到 2031 年的 19.5031 亿美元，复合年增长率为 12.39%。

皮肤镜是一种非侵入性、携带式医疗设备，它利用特定的照明和放大技术来观察深层皮肤结构，从而能够对病灶进行精确分析，用于诊断。市场成长的主要驱动力是全球皮肤癌发病率的上升以及人们越来越重视早期检测以提高患者康復率。此外，由于需要进行准确的非手术评估，皮肤镜在远距皮肤科会诊和全科诊疗中的应用日益广泛，也推动了该设备在医疗保健网络中的普及。

根据美国癌症协会估计，2024年美国将新增100,640例侵袭性黑色素瘤病例，凸显了日益严重的疾病负担，亟需有效的诊断解决方案。儘管需求迫切，但先进数位皮肤病系统的高昂以金额为准仍然是一大障碍。这项经济负担限制了发展中地区和小规模诊所的购买能力，可能阻碍全球皮肤病学市场的广泛扩张和普及。

市场驱动因素

人工智慧 (AI) 与皮肤病学的融合正在从根本上改变这一领域，它提高了诊断准确率，并最大限度地减少了对主观临床评估的依赖。将 AI 演算法与数位皮肤镜结合，使医疗专业人员能够以极高的精度分析病变的频谱模式，从而实现快速的临床决策。这项技术变革得益于近期监管方面的进展。例如，DermaSensor 在 2024 年 1 月的新闻稿中宣布其 AI 驱动的医疗设备获得 FDA 批准，并公布了关键研究结果，表明其光谱设备在 224 例皮肤癌病例中达到了 96% 的灵敏度，显着高于标准基层医疗的检出率。此类进展对于简化转诊流程以及将皮肤病学工具的效用扩展到专科诊所之外至关重要。

同时，全球皮肤癌和黑色素瘤发病率的持续上升推动了先进诊断设备的应用。恶性病变发生率的增加，使得广泛筛检计画和采用高性能皮肤镜以确保早期疗育尤为必要。为了说明这个长期趋势，美国国家皮肤癌基金会在2025年1月发布的报告显示，2015年至2025年间，美国每年新增侵袭性黑色素瘤病例数增加了42%。这种激增不仅限于北美，也加剧了国际疾病负担。根据世界卫生组织（世卫组织）2024年2月发布的全球癌症观察资料库，2022年全球约有331,722例新增皮肤黑色素瘤病例，凸显了全球普及诊断基础设施的迫切需求。

市场挑战

数位皮肤镜系统的高昂部署成本是全球皮肤镜市场扩张的一大障碍。这一经济障碍限制了市场准入，尤其对于资本支出受到严格控制的发展中地区的小规模私人诊所和医疗机构而言更是如此。当诊断设备的初始投资超出这些诊所有限的预算时，部署往往会被推迟或取消，这直接导致销售下降，并减缓了技术的普及速度。

医疗产业的经济压力进一步加剧了这个问题，限制了可用于设备现代化的资金。正如美国医学会指出的，联邦医疗保险医师收费标准转换係数将于2024年下降3.37%，这将给医疗机构带来额外的财务压力。报销水准的降低减少了医生可用于购买高成本设备的资金。因此，小规模企业无力承担这些成本，阻碍了市场在成本敏感型细分领域充分发挥其潜力。

市场趋势

远距皮肤科会诊和远距离诊断平台的兴起正成为应对医疗系统不堪重负的患者数量的关键手段。由于皮肤科长期面临人员短缺，远距分诊模式无需即时进行面对面会诊即可快速评估皮肤病变，从而有效地优先处理高风险患者。这种营运模式的转变源自于简化临床工作流程和缩短恶性肿瘤评估等待时间的迫切需求。这项需求规模庞大：如同2025年5月《药学论坛》（Pharmaphorum）一篇关于人工智慧支援英国国家医疗服务体系（NHS）的报导所指出的，英国皮肤科服务每年收到约100万例基层医疗转诊，由此产生的瓶颈需要可扩展的数位化路径来应对。

同时，基于云端的图像储存和连接解决方案的出现正在推动该行业基础设施的现代化，使市场从独立硬体转向整合诊断生态系统。製造商和软体开发人员正大力投资建立平台，以实现全科医生和专科医生之间的无缝数据传输，从而使高品质的皮肤镜图像能够透过去中心化网路即时存取。积极的资金筹措活动也印证了这一商业性发展趋势，这些活动旨在扩展数位化能力。根据HTN 2025年4月发布的报告，SkinAnalytics在资金筹措，用于扩展其云端连接诊断产品，并进军医疗人员短缺的国际市场。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球皮肤镜市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（接触式皮肤镜、混合式皮肤镜、非接触式皮肤镜）
  • 依技术（LED、氙气、卤素、紫外线）
  • 依使用方式（手持式、推车式、头戴式）
  • 外用（皮肤肿瘤、霉菌感染疾病、疣、疥疮等）
  • 依最终使用者（皮肤科诊所、医院等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美皮肤镜市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲皮肤镜市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区皮肤镜市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲皮肤镜市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲皮肤镜市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球皮肤镜市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Canfield Scientific, Inc.
• FotoFinder Systems, Inc.
• HEINE Optotechnik GmbH & Co. KG
• Caliber Imaging & Diagnostics, Inc.
• ILLUCO Corporation Ltd.
• Bio-Therapeutic, Inc.
• Optilia Instruments AB
• Rudolf Riester GmbH
• NIDEK CO., LTD.
• KIRCHNER & WILHELM GmbH+Co. KG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dermatoscope Market is projected to experience substantial growth, expanding from a value of USD 967.91 Million in 2025 to USD 1950.31 Million by 2031, representing a Compound Annual Growth Rate (CAGR) of 12.39%. Defined as a non-invasive, handheld medical instrument, a dermatoscope employs specific illumination and magnification techniques to visualize subsurface skin structures, allowing for the precise analysis of lesions for diagnostic purposes. The market's upward trajectory is primarily driven by the increasing global incidence of skin cancer and a heightened focus on early detection to enhance patient recovery rates. Furthermore, the broadening application of dermoscopy within tele-dermatology and general practice facilitates greater device adoption across healthcare networks, fueled by the necessity for accurate, non-surgical assessments.

According to the American Cancer Society, estimates for 2024 indicated that 100,640 new cases of invasive melanoma would be diagnosed in the United States, highlighting the intensifying disease burden that demands effective diagnostic solutions. Despite this critical need, a notable obstacle remains regarding the high expense associated with advanced digital dermatoscopy systems. This financial hurdle restricts purchasing capabilities in developing regions and smaller clinics, which could potentially impede the widespread expansion and penetration of the Global Dermatoscope Market.

Market Driver

The integration of artificial intelligence into dermatoscopy is fundamentally transforming the sector by improving diagnostic accuracy and minimizing reliance on subjective clinical evaluations. By pairing AI algorithms with digital dermatoscopes, practitioners can analyze lesion spectral patterns with exceptional precision, thereby enabling prompt clinical decision-making. This technological shift is validated by recent regulatory achievements; for instance, DermaSensor Inc. announced in a January 2024 press release regarding FDA clearance for an AI-powered medical device that a pivotal study showed their spectroscopy device achieved a 96 percent sensitivity rate across 224 identified skin cancers, significantly surpassing standard primary care detection rates. These advancements are essential for streamlining referral processes and extending the utility of dermatoscopic tools beyond specialized clinics.

Simultaneously, the rising global prevalence of skin cancer and melanoma acts as a continuous catalyst for the acquisition of sophisticated diagnostic instruments. The escalating frequency of malignant lesions requires widespread screening programs and the adoption of high-performance dermatoscopes to ensure early intervention. Illustrating this long-term trend, The Skin Cancer Foundation reported in January 2025 that the number of new invasive melanoma cases diagnosed annually in the United States rose by 42 percent between 2015 and 2025. This surge extends beyond North America, as the disease burden grows internationally; according to the World Health Organization's February 2024 'Global Cancer Observatory' database, approximately 331,722 new cases of cutaneous melanoma were diagnosed globally in 2022, underscoring the urgent worldwide need for accessible diagnostic infrastructure.

Market Challenge

The substantial cost required to acquire digital dermatoscopy systems serves as a significant restraint on the expansion of the Global Dermatoscope Market. This financial barrier limits market access, particularly for smaller private practices and healthcare facilities in developing regions where capital expenditure is tightly controlled. When the upfront investment for diagnostic instrumentation exceeds the limited budgets of these clinics, procurement is often postponed or cancelled, which directly reduces the volume of unit sales and slows the rate of technology adoption.

Economic pressures within the broader healthcare industry further exacerbate this issue by restricting the funds available for equipment modernization. As noted by the American Medical Association, the conversion factor for the Medicare Physician Fee Schedule was reduced by 3.37 percent in 2024, placing additional financial strain on medical practices. This contraction in reimbursement levels diminishes the disposable capital that physicians can allocate toward high-cost devices. Consequently, the inability of smaller entities to absorb these expenses prevents the market from reaching its full potential in cost-sensitive segments.

Market Trends

The growth of teledermatology and remote diagnostic platforms is becoming a vital mechanism for managing the excessive volume of patient cases overwhelming healthcare systems. With dermatology departments facing chronic workforce shortages, remote triage models allow for the rapid assessment of skin lesions without the need for immediate face-to-face consultations, thereby effectively prioritizing high-risk patients. This operational shift is driven by the urgent necessity to streamline clinical workflows and reduce wait times for malignancy assessments. The scale of this demand is substantial; as highlighted in a May 2025 Pharmaphorum article regarding AI support for the NHS, dermatology services in the United Kingdom receive approximately one million referrals annually from primary care, creating a bottleneck that necessitates scalable digital pathways.

Concurrently, the emergence of cloud-based image storage and connectivity solutions is modernizing the sector's infrastructure, moving the market from standalone hardware toward integrated diagnostic ecosystems. Manufacturers and software developers are securing significant capital to build platforms that facilitate seamless data transfer between general practitioners and specialists, ensuring that high-quality dermatoscopic images are instantly accessible across distributed networks. This commercial trajectory is evidenced by robust financial activity aimed at scaling these digital capabilities; according to an April 2025 report by HTN, Skin Analytics raised £15 million in Series B funding to expand its cloud-connected diagnostic product offerings and extend its reach into international markets struggling with practitioner scarcity.

Key Market Players

• Canfield Scientific, Inc.
• FotoFinder Systems, Inc.
• HEINE Optotechnik GmbH & Co. KG
• Caliber Imaging & Diagnostics, Inc.
• ILLUCO Corporation Ltd.
• Bio-Therapeutic, Inc.
• Optilia Instruments AB
• Rudolf Riester GmbH
• NIDEK CO., LTD.
• KIRCHNER & WILHELM GmbH + Co. KG

Report Scope

In this report, the Global Dermatoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatoscope Market, By Product

• Contact Dermatoscope
• Hybrid Dermatoscope
• Noncontact Dermatoscope

Dermatoscope Market, By Technology

• LED
• Xenon
• Halogen
• Ultraviolet

Dermatoscope Market, By Modality

• Handheld
• Trolley Mounted
• Headband

Dermatoscope Market, By Application

• Skin Tumors
• Fungal Infections
• Warts
• Scabies
• Others

Dermatoscope Market, By End User

• Dermatology Clinics
• Hospitals
• Others

Dermatoscope Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatoscope Market.

Available Customizations:

Global Dermatoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatoscope Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Contact Dermatoscope, Hybrid Dermatoscope, Noncontact Dermatoscope)
  • 5.2.2. By Technology (LED, Xenon, Halogen, Ultraviolet)
  • 5.2.3. By Modality (Handheld, Trolley Mounted, Headband)
  • 5.2.4. By Application (Skin Tumors, Fungal Infections, Warts, Scabies, Others)
  • 5.2.5. By End User (Dermatology Clinics, Hospitals, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Dermatoscope Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Modality
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermatoscope Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Modality
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Dermatoscope Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Modality
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Dermatoscope Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Modality
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Dermatoscope Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Modality
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermatoscope Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Modality
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Dermatoscope Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Modality
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Dermatoscope Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Modality
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Dermatoscope Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Modality
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Dermatoscope Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Modality
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Dermatoscope Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Modality
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dermatoscope Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Modality
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Dermatoscope Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Modality
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Dermatoscope Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Modality
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Dermatoscope Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Modality
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Dermatoscope Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Modality
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Dermatoscope Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Modality
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dermatoscope Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Modality
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Dermatoscope Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Modality
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Dermatoscope Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Modality
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Dermatoscope Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Modality
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dermatoscope Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Modality
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Dermatoscope Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Modality
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Dermatoscope Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Modality
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dermatoscope Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Canfield Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. FotoFinder Systems, Inc.
• 15.3. HEINE Optotechnik GmbH & Co. KG
• 15.4. Caliber Imaging & Diagnostics, Inc.
• 15.5. ILLUCO Corporation Ltd.
• 15.6. Bio-Therapeutic, Inc.
• 15.7. Optilia Instruments AB
• 15.8. Rudolf Riester GmbH
• 15.9. NIDEK CO., LTD.
• 15.10. KIRCHNER & WILHELM GmbH + Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer